Viewing StudyNCT00379795



Ignite Creation Date: 2024-05-05 @ 5:02 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00379795
Status: COMPLETED
Last Update Posted: 2017-05-11
First Post: 2006-09-21

Brief Title: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO
Sponsor: Genentech Inc
Organization: Genentech Inc

Conditions & Keywords Data

Conditions:
Name
Choroidal Neovascularization Age-related Macular Degeneration
Keywords:
Name View
RVO View
CNV View
Lucentis View
AMD View
Age-related macular degeneration View